SPC Premium Dossier: Royalty Pharma

This is one of our newest Model Portfolio stocks ...

Author

Stock Picker's Corner (SPC)
June 19, 2026

We’re hurtling toward the “Next Patent Cliff.”

I’ve seen it before.

For biotech investors, I know it’s a big risk … for the uninitiated.

But for smart Wealth Builders like us, it’s a massive opportunity.

Continue Reading

This analysis continues inside Stock Picker’s Corner. Subscribers get access to our full breakdowns of well‑positioned businesses, how we think about risk and opportunity when markets get volatile, and how we approach building positions over time. That includes our reasoning behind each idea, ongoing updates as conditions change, and practical guidance on when to start buying and how to add gradually without trying to time the market. If you’re looking for research that goes beyond headlines and short‑term price moves, you’re in the right place.

Already a paying subscriber? Sign In.